Copyright Reports & Markets. All rights reserved.

Global Epigenome Sequencing Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Epigenome Sequencing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Epigenome Sequencing Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 DNA Methylation
    • 1.3.3 Histone Modification
    • 1.3.4 Non-coding RNA
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Epigenome Sequencing Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Biomedical Field
    • 1.4.3 Non-medical Field
  • 1.5 Global Epigenome Sequencing Market Size & Forecast
    • 1.5.1 Global Epigenome Sequencing Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Epigenome Sequencing Sales Quantity (2018-2029)
    • 1.5.3 Global Epigenome Sequencing Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Illumina
    • 2.1.1 Illumina Details
    • 2.1.2 Illumina Major Business
    • 2.1.3 Illumina Epigenome Sequencing Product and Services
    • 2.1.4 Illumina Epigenome Sequencing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Illumina Recent Developments/Updates
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Epigenome Sequencing Product and Services
    • 2.2.4 Thermo Fisher Scientific Epigenome Sequencing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.3 Bio-Rad
    • 2.3.1 Bio-Rad Details
    • 2.3.2 Bio-Rad Major Business
    • 2.3.3 Bio-Rad Epigenome Sequencing Product and Services
    • 2.3.4 Bio-Rad Epigenome Sequencing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Bio-Rad Recent Developments/Updates
  • 2.4 Agilent Technologies
    • 2.4.1 Agilent Technologies Details
    • 2.4.2 Agilent Technologies Major Business
    • 2.4.3 Agilent Technologies Epigenome Sequencing Product and Services
    • 2.4.4 Agilent Technologies Epigenome Sequencing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Agilent Technologies Recent Developments/Updates
  • 2.5 QIAGEN
    • 2.5.1 QIAGEN Details
    • 2.5.2 QIAGEN Major Business
    • 2.5.3 QIAGEN Epigenome Sequencing Product and Services
    • 2.5.4 QIAGEN Epigenome Sequencing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 QIAGEN Recent Developments/Updates
  • 2.6 Psomagen
    • 2.6.1 Psomagen Details
    • 2.6.2 Psomagen Major Business
    • 2.6.3 Psomagen Epigenome Sequencing Product and Services
    • 2.6.4 Psomagen Epigenome Sequencing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Psomagen Recent Developments/Updates
  • 2.7 BGI Genomics
    • 2.7.1 BGI Genomics Details
    • 2.7.2 BGI Genomics Major Business
    • 2.7.3 BGI Genomics Epigenome Sequencing Product and Services
    • 2.7.4 BGI Genomics Epigenome Sequencing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 BGI Genomics Recent Developments/Updates
  • 2.8 Zhijiang Biology
    • 2.8.1 Zhijiang Biology Details
    • 2.8.2 Zhijiang Biology Major Business
    • 2.8.3 Zhijiang Biology Epigenome Sequencing Product and Services
    • 2.8.4 Zhijiang Biology Epigenome Sequencing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Zhijiang Biology Recent Developments/Updates
  • 2.9 PacBio
    • 2.9.1 PacBio Details
    • 2.9.2 PacBio Major Business
    • 2.9.3 PacBio Epigenome Sequencing Product and Services
    • 2.9.4 PacBio Epigenome Sequencing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 PacBio Recent Developments/Updates

3 Competitive Environment: Epigenome Sequencing by Manufacturer

  • 3.1 Global Epigenome Sequencing Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Epigenome Sequencing Revenue by Manufacturer (2018-2023)
  • 3.3 Global Epigenome Sequencing Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Epigenome Sequencing by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Epigenome Sequencing Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Epigenome Sequencing Manufacturer Market Share in 2022
  • 3.5 Epigenome Sequencing Market: Overall Company Footprint Analysis
    • 3.5.1 Epigenome Sequencing Market: Region Footprint
    • 3.5.2 Epigenome Sequencing Market: Company Product Type Footprint
    • 3.5.3 Epigenome Sequencing Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Epigenome Sequencing Market Size by Region
    • 4.1.1 Global Epigenome Sequencing Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Epigenome Sequencing Consumption Value by Region (2018-2029)
    • 4.1.3 Global Epigenome Sequencing Average Price by Region (2018-2029)
  • 4.2 North America Epigenome Sequencing Consumption Value (2018-2029)
  • 4.3 Europe Epigenome Sequencing Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Epigenome Sequencing Consumption Value (2018-2029)
  • 4.5 South America Epigenome Sequencing Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Epigenome Sequencing Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Epigenome Sequencing Sales Quantity by Type (2018-2029)
  • 5.2 Global Epigenome Sequencing Consumption Value by Type (2018-2029)
  • 5.3 Global Epigenome Sequencing Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Epigenome Sequencing Sales Quantity by Application (2018-2029)
  • 6.2 Global Epigenome Sequencing Consumption Value by Application (2018-2029)
  • 6.3 Global Epigenome Sequencing Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Epigenome Sequencing Sales Quantity by Type (2018-2029)
  • 7.2 North America Epigenome Sequencing Sales Quantity by Application (2018-2029)
  • 7.3 North America Epigenome Sequencing Market Size by Country
    • 7.3.1 North America Epigenome Sequencing Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Epigenome Sequencing Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Epigenome Sequencing Sales Quantity by Type (2018-2029)
  • 8.2 Europe Epigenome Sequencing Sales Quantity by Application (2018-2029)
  • 8.3 Europe Epigenome Sequencing Market Size by Country
    • 8.3.1 Europe Epigenome Sequencing Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Epigenome Sequencing Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Epigenome Sequencing Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Epigenome Sequencing Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Epigenome Sequencing Market Size by Region
    • 9.3.1 Asia-Pacific Epigenome Sequencing Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Epigenome Sequencing Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Epigenome Sequencing Sales Quantity by Type (2018-2029)
  • 10.2 South America Epigenome Sequencing Sales Quantity by Application (2018-2029)
  • 10.3 South America Epigenome Sequencing Market Size by Country
    • 10.3.1 South America Epigenome Sequencing Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Epigenome Sequencing Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Epigenome Sequencing Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Epigenome Sequencing Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Epigenome Sequencing Market Size by Country
    • 11.3.1 Middle East & Africa Epigenome Sequencing Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Epigenome Sequencing Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Epigenome Sequencing Market Drivers
  • 12.2 Epigenome Sequencing Market Restraints
  • 12.3 Epigenome Sequencing Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Epigenome Sequencing and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Epigenome Sequencing
  • 13.3 Epigenome Sequencing Production Process
  • 13.4 Epigenome Sequencing Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Epigenome Sequencing Typical Distributors
  • 14.3 Epigenome Sequencing Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Epigenome Sequencing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Epigenome Sequencing market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Epigenome Sequencing market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Epigenome Sequencing market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Epigenome Sequencing market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Epigenome Sequencing market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Epigenome Sequencing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Epigenome Sequencing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies and QIAGEN, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Epigenome Sequencing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    DNA Methylation
    Histone Modification
    Non-coding RNA
    Market segment by Application
    Biomedical Field
    Non-medical Field
    Major players covered
    Illumina
    Thermo Fisher Scientific
    Bio-Rad
    Agilent Technologies
    QIAGEN
    Psomagen
    BGI Genomics
    Zhijiang Biology
    PacBio
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Epigenome Sequencing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Epigenome Sequencing, with price, sales, revenue and global market share of Epigenome Sequencing from 2018 to 2023.
    Chapter 3, the Epigenome Sequencing competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Epigenome Sequencing breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Epigenome Sequencing market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Epigenome Sequencing.
    Chapter 14 and 15, to describe Epigenome Sequencing sales channel, distributors, customers, research findings and conclusion.

    Buy now